MedPath

Investigating the effects of acute tryptophan loading on attention and impulsivity in adults with and without Attention Deficit Hyperactivity Disorder (ADHD)

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Mental and Behavioural Disorders
Registration Number
ISRCTN15119603
Lead Sponsor
King's College London
Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38033150/ (added 05/12/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
144
Inclusion Criteria

All participants:
1. Adults aged 18-35 years

Healthy control participants (HC):
2. No diagnosis of ADHD and score on the Adult ADHD Self-Report Scale below the threshold indicative of ADHD.

ADHD
3. Existing current diagnosis of ADHD and score on the Adult ADHD Self-Report Scale above the threshold indicative of ADHD.
4. Either not receiving ADHD medication and have not received any for a period of at least 3 months or receiving medication for ADHD (psychostimulant or non-stimulant) and adhering to this with a rate of at least 70%.

Exclusion Criteria

1. Gluten or lactose intolerance, as participants will be asked to ingest a whey protein drink
2. Current or past diagnosis of nutritional, psychiatric (excluding ADHD) or neurological illnesses
3. Being pregnant/breastfeeding
4. Being a smoker (including e-cigarettes)
5. Currently taking medication known to affect the serotonergic system such as antidepressants
6. Learning disabilities
7. Following a restrictive diet (e.g. keto), as this might interfere with the experiment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measured pre and post intervention (baseline and ~1 hour):<br>1. Attention measured using the computerised Test of Variable of Attention (TOVA) task (omission errors, response sensitivity, reaction time). <br>2. Motor impulsivity measured using the computerised Test of Variable of Attention (TOVA) task (commission errors).<br>3. Temporal impulsivity measured using the computerised Delay Discounting Task (indifference points, discounting function, area under the curve).<br>4. Cognitive impulsivity measured using the computerised Iowa Gambling Task (proportion of risky decisions, net score).
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath